Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company was founded by Paul A. Hopper in 2021 and is headquartered in Carlton, Australia.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
14
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Radiopharm Theranostics Ltd - ADR market cap is $9.9M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Radiopharm Theranostics Ltd - ADR 52 week high is $16.25 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Radiopharm Theranostics Ltd - ADR 52 week low is $0.63 as of November 22, 2026.
Radiopharm Theranostics Ltd - ADR stock price today is $0.6304.
Radiopharm Theranostics Ltd - ADR stock price yesterday was $0.673.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Radiopharm Theranostics Ltd - ADR's P/E ratio is -0.2.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Radiopharm Theranostics Ltd - ADR P/B ratio is 0.4354.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Radiopharm Theranostics Ltd - ADR 50-day moving average is $1.15.
Radiopharm Theranostics Ltd - ADR has 14 employees.